Related Insights
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Case Study
Case study: Achieving a 7-week study start-up in a first in human autoimmune study
Jun 23, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
Playbook
Real‑world evidence as a strategic architecture for precision hematology
May 29, 2026
Playbook
Hematology trials demand data-driven feasibility, expert site selection, and hyper-efficient start-up
May 29, 2026
Playbook
Navigating regulatory divides: Strategic diplomacy in rare hematology
May 29, 2026
Playbook
Five strategies to build a better non-malignant hematology drug by listening to patients
May 29, 2026
Playbook
How smarter trial design can derisk and accelerate your malignant hematology asset
May 29, 2026
Related Insights
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Case Study
Case study: Achieving a 7-week study start-up in a first in human autoimmune study
Jun 23, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
Playbook
Real‑world evidence as a strategic architecture for precision hematology
May 29, 2026
Playbook
Hematology trials demand data-driven feasibility, expert site selection, and hyper-efficient start-up
May 29, 2026
Playbook
Navigating regulatory divides: Strategic diplomacy in rare hematology
May 29, 2026
Playbook
Five strategies to build a better non-malignant hematology drug by listening to patients
May 29, 2026
Playbook
How smarter trial design can derisk and accelerate your malignant hematology asset
May 29, 2026